# Brolucizumab Efficacy and Safety Single-Arm Descriptive Trial in Patients With Persistent Diabetic Macular Edema

> **NCT06498050** · PHASE4 · ACTIVE_NOT_RECRUITING · sponsor: **Guangdong Provincial People's Hospital** · enrollment: 52 (actual)

## Conditions studied

- Diabetic Macular Edema

## Interventions

- **DRUG:** intravitreal injection of Brolucizumab 6 mg in study eye

## Key facts

- **NCT ID:** NCT06498050
- **Lead sponsor:** Guangdong Provincial People's Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2024-07-10
- **Primary completion:** 2025-07-10
- **Final completion:** 2025-07-10
- **Target enrollment:** 52 (ACTUAL)
- **Last updated:** 2025-06-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06498050

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06498050, "Brolucizumab Efficacy and Safety Single-Arm Descriptive Trial in Patients With Persistent Diabetic Macular Edema". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06498050. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*